Editas Medicine EDIT reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Editas Medicine beat estimated earnings by 8.97%, reporting an EPS of $-0.71 versus an estimate of $-0.78.
Revenue was up $3.08 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 3.69% drop in the share price the next day.
Here's a look at Editas Medicine's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.80 | -0.86 | -0.82 | -0.79 |
EPS Actual | -0.88 | -0.81 | -0.78 | -0.74 |
Revenue Estimate | 3.26M | 4.73M | 4.29M | 3.85M |
Revenue Actual | 6.54M | 42K | 6.36M | 6.77M |
To track all earnings releases for Editas Medicine visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.